Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Rise in drug spending widens France’s social security deficit
CCSS, the social security auditor, has found a 4.2% increase in the spending on drugs in partial, preliminary accounts for 2007. This substantial increase in spending has led
CCSS, the social security auditor, has found a 4.2% increase in the spending on drugs in partial, preliminary accounts for 2007. This substantial increase in spending has led
The research ministry and Afssaps, the medicines regulator, in corroboration with 10 other agencies and organisations have formed a scientific interest group to reduce or eliminate unnecessary animal
According to Louis Galambos, professor of economic and business history at the Johns Hopkins University in the US, the increasing drug development costs coupled with the governmental pressures
Data from preclinical studies and from the company’s Retime 1.0 study demonstrated that cardiac electric tomography (CET) quantifies important aspects of cardiac performance using an automated, operator-independent technique
Terms of the termination include a repayment of the initial $2.6 million license fee originally paid to Scient’x and a full repayment of inventory that Alphatec will return
The trial includes 1,820 patients and examines the potential benefits of Boston Scientific cardiac resynchronization therapy defibrillators (CRT-Ds) in a new population of heart failure patients. It is
R7128, a prodrug of PSI-6130, is a nucleoside analogue polymerase inhibitor of hepatitis c virus (HCV) that is being developed through Pharmasset’s collaboration with Roche. Cohort 3 will
RotaTeq is a live, oral pentavalent vaccine indicated for the prevention of rotavirus gastroenteritis. Pablo Legorreta, CEO of Royalty Pharma, said: “With the addition of this royalty on
In clinical studies, Relistor significantly decreased the constipating effects of opioids without interfering with pain relief. Wyeth expects to make Relistor available in the US in early June,
The contract calls for Pharmavite’s exclusive rights to Reducol in the US mass-market distribution channel. Pharmavite is expected to support the CholestOff and CholestOff Complete brands through various